PMID: 6167687Jan 1, 1981Paper

HLA-antigens and the prognosis of multiple sclerosis

Journal of Neurology
S PoserN E Raun

Abstract

The histocompatibility pattern of 160 patients with multiple sclerosis (MS) living in the epidemiological area of Southern Lower Saxony was determined and compared to a control population. The only significant difference was the more frequent occurrence of DW2 in the patient group (44% vs. 21%). Taking a progression index (grade of disability divided by the duration of the disease) as a measure for prognosis no difference could be found between the DW2 positive and the DW2 negative patients. The reason why we could not confirm the worse prognosis for DW2 positive patients found by Jersild et al. (1973) and Raun et al. (1980) remains to be investigated.

References

Jun 1, 1979·Acta Neurologica Scandinavica·L Stendahl-BrodinE Norrby
Jan 1, 1972·Tissue Antigens·S NaitoP I Terasaki

❮ Previous
Next ❯

Citations

May 1, 1994·Journal of Neurology·B RunmarkerO Andersen
Aug 1, 1984·Journal of the Neurological Sciences·E KinnunenJ Wikström
Jan 1, 1992·Molecular Aspects of Medicine·M Baines, A Ebringer
Oct 6, 2000·Journal of the Neurological Sciences·E G CeliusA Spurkiand
Nov 16, 2012·PloS One·Satoshi YoshimuraUNKNOWN South Japan Multiple Sclerosis Genetics Consortium
Jul 30, 1999·Journal of the Neurological Sciences·G V McDonnellD Middleton
Mar 7, 2002·Journal of Neuroimmunology·Orhun H KantarciBrian G Weinshenker
Jul 18, 2008·Journal of Neuroimmunology·Sreeram V RamagopalanGeorge C Ebers
Apr 7, 2007·Journal of the Neurological Sciences·Ana Martins SilvaBerta Martins
Dec 1, 1982·Acta Neurologica Scandinavica·H J Meyer-RieneckerK V Richter
Jan 22, 2005·Neurologic Clinics·Jorge R Oksenberg, Stephen L Hauser
Dec 18, 2013·Journal of the Neurological Sciences·Gulibahaer AinidingUNKNOWN South Japan Multiple Sclerosis Genetics Consortium
Jun 11, 2014·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Mohamed H TawdyAmany Hussien Abol Magd
Apr 25, 2012·Multiple Sclerosis : Clinical and Laboratory Research·Noriko IsobeJun-ichi Kira
Jun 24, 2005·Genes and Immunity·J R Oksenberg, L F Barcellos
Feb 9, 2002·Brain : a Journal of Neurology·L F BarcellosUNKNOWN Multiple Sclerosis Genetics Group
Aug 1, 1987·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·B G Weinshenker, G C Ebers
Jun 29, 2017·Arquivos de neuro-psiquiatria·Alyne Mendonça Marques TonRegina Maria Papais Alvarenga
Sep 1, 1982·Acta Neurologica Scandinavica·S PoserW Poser
May 1, 1985·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·P DuquetteY Lapierre

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.